Jae-WooPark, JeungwonYoon, Chong-KwanCho, Yeon-WeolLee, Hwa-SeungYoo. (2012) Survival analysis of stage IV metastatic gastric cancer patients treated with HangAm-Plus. Chinese Journal of Integrative Medicine /Survival analysis of stage IV metastatic gastric cancer patients treated with HangAm-...
The prognosis of patients with Stage IV gastric cancer is generally poor. The 5-year overall survival rate is less than 10%. The patient was a 73-year-old man with Stage IV gastric cancer. Before chemotherapy, peritoneal dissemination was observed using staging laparoscopy. The patient received...
These results suggest that to promote long-term survival in stage IV gastric cancer cases, curative B operation and postoperative immunochemotherapy are indicated in cases that have P0, H0 and some metastasis to group 3 or 4 lymph nodes histologically. The prognosis for P(+) and H(+) cases ...
According to TNM categories, we separated them into T1-3N3M0, T4N1-2M0, T4N3M0, And TanyNanyM1 groups.: The survival rate of patients with subclassification IVa (T1-3N3M0 and T4N1-2M0) was significant higher than that of patients with sub-classification IVb (T4N3M0 and TanyNanyM1...
(operation time, volume of blood loss, number of lymph node dissected and surgical margin) and postoperative situations (complications and duration of hospital stay); (3) comparison of followup and survival between the 2 groups; (4) prognostic factors analysis affecting stage Ⅳ gastric cancer ...
1 In China, the incidence of gastric cancer ranks second among all cancers.2 From 2012 to 2015, the 5-year survival rate of patients with gastric cancer in China was 35.1%,3 which was much lower than that in Japan (71.3%) during the same period.4 However, the National Cancer Center ...
In advanced gastric cancer patients treated mainly with 5-FU or cisplatin-based chemotherapy, lower expression of EGFR mRNA than the cutoff value was a strong predictor of poor survival by multivariate analysis (Matsubara et al, 2008a). Interestingly, the authors also showed that high DPD and ...
Sugemalimab Demonstrates Statistically Significant Overall Survival Benefit in Patients With Stage IV Non-Small Cell Lung Cancer. News release. EGRx; January 18, 2022. Accessed January 19, 2022. https://www.eqrx.com/press-release/sugemalimab-demonstrates-statistically-significant-overal...
Stage migration secondary to meticulous lymph node dissection affects stage-specific survival rates. True therapeutic survival benefit of D3 resection can only be assessed in this context. 展开 关键词: Stage migration Gastric cancer Surgical randomised trial ...
Radical gastrectomy (RG) with lymph node (LN) dissection is a standard procedure for gastric cancer (GC). Patients with end-stage renal disease (ESRD) usually have high risk for any operative procedure. However, information for ESRD on RG for GC is limited.A total of 2,021 GC patients wh...